flumazenil has been researched along with Delusional Disorder in 1 studies
Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.
Delusional Disorder: Disorder with presentation of a facade of coldness with characteristic pervasive mistrust and suspiciousness of others.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Suzuki, K | 1 |
Takano, T | 1 |
Fujiyama, K | 1 |
Tanabe, Y | 1 |
Matsuoka, H | 1 |
1 other study available for flumazenil and Delusional Disorder
Article | Year |
---|---|
Panic attack associated with flumazenil at electroconvulsive therapy session.
Topics: Electroconvulsive Therapy; Female; Flumazenil; GABA Modulators; Humans; Middle Aged; Panic Disorder; | 2009 |